Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Status:
Completed
Trial end date:
2019-08-07
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of Niacinamide
supplementation on clinical outcome of fatty liver patients having type II DM through
measurement of the following before and after Niacinamide administration: Liver enzymes,
Lipid profie, HOMA-IR, Oxidative stress markers and endothelial dysfunction marker. Fibroscan
with CAP will be done at baseline and at the end of the trial. Also, Evaluation of quality of
life of patients before and after Niacinamide administration using Chronic Liver Disease
questionnaire.